Product image of Vyxeos Liposomal (Daunorubicin Hydrochloride, Cytarabine) supplied by GNH India

Vyxeos Liposomal

Active Ingredient:
Daunorubicin Hydrochloride, Cytarabine
Origin:
EU

Vyxeos Liposomal (Daunorubicin Hydrochloride, Cytarabine)

Vyxeos Liposomal is a chemotherapy combination therapy used for the treatment of acute myeloid leukemia. This liposomal formulation delivers daunorubicin and cytarabine in a fixed ratio for targeted delivery. It is administered intravenously under medical supervision.

Manufacturer / TM Owner

Jazz Pharmaceuticals Ireland Ltd

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Vyxeos Liposomal is used to treat acute myeloid leukemia (AML), a type of cancer that starts in the bone marrow. It combines daunorubicin and cytarabine in a liposomal formulation to improve delivery to cancer cells. This medication is typically used for patients with newly diagnosed therapy-related AML or AML with myelodysplasia-related changes. It may also be used in other AML cases as determined by a healthcare provider.

Side Effects

  • Vyxeos Liposomal works by slowing or stopping the growth of cancer cells in the body. The liposomal delivery system helps concentrate the active ingredients at the site of the tumor. Patients may experience effects such as reduced fatigue or improved blood cell counts over time. Individual responses vary based on treatment duration and health status.

Precautions & Warnings

  • Vyxeos Liposomal should only be handled and administered by healthcare professionals in a clinical setting. Patients may need regular blood tests to monitor for side effects like low blood cell counts. It is important to stay hydrated and follow all medical instructions during treatment. Avoid exposure to infections and report any unusual symptoms promptly.

Avoid Interactions

  • Vyxeos Liposomal may interact with other medications, including certain antibiotics, antifungals, or drugs that affect the immune system. Alcohol and herbal supplements should be avoided unless approved by a doctor. Live vaccines are not recommended during treatment. Always inform your healthcare provider about all medications and supplements you are taking.

Frequently Asked Questions

Vyxeos Liposomal is used to treat acute myeloid leukemia (AML), particularly in patients with newly diagnosed therapy-related AML or AML with myelodysplasia-related changes.

Vyxeos Liposomal is given as an intravenous infusion in a healthcare setting, typically over a period of 90 minutes.

Common side effects may include low blood cell counts, fatigue, and infections. Your doctor will monitor you for these effects during treatment.

Some medications may interact with Vyxeos Liposomal. Always inform your healthcare provider about all medications and supplements you are taking.

Vyxeos Liposomal is prescribed based on individual health conditions. Discuss your medical history with your doctor to determine if it is suitable for you.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated:

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Daunorubicin Hydrochloride, Cytarabine

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT